• Products
  • Community
  • Markets
  • Brokers
  • More
Get started
  • Markets
  • /Germany
  • /Stocks
  • /Ideas
DroneShield: Hit and Run!We recently switched our DroneShield charts to the Munich-based gettex exchange. As a result, we are now analyzing the price in Euro (instead of Australian dollars) — however, this does not change our wave count, our expectations, or our scenarios. Since our last update, DroneShield’s stock has continued to move higher and has thus confirmed the corrective low. We closed half of our long trade that was opened on March 4, 2026. We are remaining in the market with the other half of the position and are protecting it with a stop at €2.02. Alternative scenario However, if downside pressure increases significantly and the stock even falls below the support at €1.61, our alternative scenario would be activated. In that case, we would assume that a lower low will be formed within our alternative long-term entry zone (coordinates: €1.56 – €1.03) (probability: 20%). Thereafter, the upward move described above would likewise unfold.
GETTEX:DRHLong
01:43
by HKCM_Global
Takeoff after cooldown?Infineon is clearly bullish since a while and even set a new ATH but i think that's just the beginnig, since the german company lurked in the shadows of the giants so far. So let's give the breakout a checkmark and prepare for what might come next. I see a bearish divergence in the weekly and the chart is dancing around the upper point of control. This might send the price back to test the 100 EMA or even the 200 EMA. With a short downfall, the chart may gather some new momentum to take off. There would be plenty of headroom in the RSI. Even if the chart decides to plot a few large green candles now, i believe there will be a better entry spot coming soon.
XETR:IFXLong
by Klataro
Updated
Symmetrical compression (potentially explosive)Drone warfare is now a reality: those who manufacture drones will certainly win, but those who can take them down are just as essential. Some info: DroneShield is an Australian company experiencing extremely rapid growth due to the global surge in demand for anti‑drone technologies. In 2025, it recorded revenue growth of 276–277%, reaching AUD 216.5 million, and returned to stable profitability with AUD 210 million in cash and zero debt. Its order pipeline has reached AUD 2.3 billion, supported by military contracts in Europe, the US, and the Middle East. The company is also expanding production capacity to AUD 2.4 billion per year by 2026 to meet rising demand. The stock has gained over 286% in the past year, boosted by strong growth in its software (SaaS) segment, which increases recurring revenue and margins. What does DroneShield produce? DroneShield specializes in C‑UAS (Counter‑Unmanned Aerial Systems) technologies—systems designed to detect, identify, and neutralize hostile drones. It produces: Portable anti‑drone systems, including handheld devices, accessories, and software updates, such as those involved in recent AUD 49.6 million European contracts. Advanced sensors, including RF, acoustic, and optical detectors, capable of identifying drones at long distances. Jamming systems and “drone‑defeat” technologies used by militaries and critical infrastructure in over 70 countries. Software and SaaS platforms for threat analysis, control, and management—one of the company’s fastest‑growing segments, up more than 300% in a year. ---- Analysis The price is currently moving within a symmetrical compression triangle that has now reached its apex. A breakout could occur today or, more likely, next week. The breakout from a compression triangle generally leads to a strong move in the direction of the breakout, making this a good time to start monitoring the setup. Updates will follow. If you appreciate my ideas, I’d be grateful for a like.
TRADEGATE:DRH
by balinor
BAYN MonthlyThe price chart is trading within a descending channel. Last month closed with a rejection at the resistance line. My primary target is €21.52.
XETR:BAYNShort
by Enduro1
44
Long on thyssenkrupp nucera AG & CO. KGaA (Ticker NCH2) XETR:NCH2 Technicals: - the price has been glued to the 9.23 resistance level and zone for a month - a breakout above this level opens the path to close the gap from Oct 22 - the month-long accumulation suggests that large-scale capital is building a position within the 8.77 – 9.20 range - the recent squeeze to the 0.23 fibo is nothing more than a stop-loss hunt targeting late-entry passengers who jumped on the train - scenario invalidated if 2 bar close below 8.77 Fundamentals: - alkaline water electrolysis (AWE) is considered one of the most reliable and scalable - maintains a strong balance sheet (net cash position), allowing it to finance expansion without incurring expensive debt - a large order backlog provides high visibility for future revenue - however, profitability remains questionable. Despite being profitable at the gross margin level, operating profit frequently fluctuates near zero or turns negative - increasing pressure from Chinese companies adds fuel to the fire regarding the asset's future valuation Conclusion: - this trade represents an interesting speculative position on a breakout of the monthly resistance zone - but a wider stop at 8.33 is only justified if the Take Profit (TP) is set at 11.65. While theoretically achievable, this target is not guaranteed and would likely require strong fundamental catalysts # - - - - - ⚠️ Signal - Buy ⬆️ ✅ Entry Point Term - 9.13 # - - - - - 🛑 SL - 8.76 🤑 TP - 10.46 ⚙️ Risk/Reward - 1 : 2.85 👌 ⌛️ Timeframe - 3 months 🗓 # - - - - - Good Luck! ☺️ DISCLAIMER: Not financial advice. Everyone must make trading decisions at their own risk, guided only by their own criteria and strategy for opening or not opening a trade.
XETR:NCH2Long
by TotSamiyKaa
Updated
22
AIXA breakout to 27€ Breakout over multi week consolidation area in full effect supported by long term vwap, 200 DMA and strong price action AIXA is aiming for 27€
TRADEGATE:AIXALong
by vvedding
Updated
Milk the cow?GFT Technologies is looking fundamentally interesting at the moment. Revenue has grown by around 3 percent in the latest report. The forward P/E ratio is not particularly attractive, but most other metrics appear stable. From a technical perspective, the volume profile is showing a P-shaped structure. This typically signals short-covering or responsive buying after a sell-off. On the chart, the value area high and the point of control are positioned close to each other, while the value area low sits below as the lower boundary. This structure can indicate potential for upside continuation, but it still requires confirmation. Currently, we have several technical factors aligning. Price is interacting with the volume-weighted average price, the point of control, and the P-shaped volume profile. That cluster makes this area technically important. From a longer-term perspective, I am viewing this as a multi-year setup. The horizon I am watching extends into the early 2030s, with a potential target implying significant upside if execution and market conditions align. Historically, the stock has shown a pattern of recovering after pullbacks. Looking back to the early 2000s, the broader trend has been structurally upward, though of course past behavior does not guarantee future performance. On the financial side, the company has continued to grow, though debt has increased in recent years, rising from roughly $82 million to about $160 million. This is not necessarily a red flag, but it is a metric that should remain under observation. GFT is a technology firm providing IT services primarily to the financial industry. It operates across the Americas, the UK, Continental Europe, and other regions. The company is headquartered in Stuttgart, Germany. Leadership continuity is another supportive factor. CEO Marco Santos has deep internal experience, having progressed from regional leadership roles to the top position. He has stepped back from outside commitments and is now fully focused on leading the company, which is generally a constructive signal. Bottom line. Fundamentally, the company looks stable but not flawless. Technically, price is sitting in an interesting zone that could develop into a larger move if confirmed. Whether it is a buy depends on your own framework, risk tolerance, and validation process. Always run your own analysis and peer comparisons. From a top-down perspective, remember that the German economy is closely linked to both the broader European cycle and the U.S. environment. Monitoring macro conditions across these regions remains important for this name. Disclaimer: This content reflects personal market opinions and is shared for educational and informational purposes only. It does not constitute financial, investment, or trading advice. Always conduct your own research and assess your risk before making any investment decisions. Past performance is not indicative of future results.
XETR:GFTLong
by Risk_Adj_Return
Drink your pain away with Pernod Ricard?During the pandemic, Pernod Ricard, one of the largest spirits producers, saw strong upside. Recently, however, the stock has been correcting. The angle I am watching is more defensive in nature. In weaker economic environments, alcohol demand has historically shown resilience as consumer behavior shifts during periods of stress. That is the broader thesis behind this setup. Despite the broader market pressure, we are starting to see early attempts to push higher. That said, the overall market has not fully stabilized, so this level needs to be monitored carefully. Fundamentally, the company looks solid. Net margins are around 14 percent, which may appear modest, but for this industry it is within a reasonable range. From a strategic standpoint, Pernod Ricard continues expanding its distribution footprint, particularly in China and other international markets. The brand portfolio is well established. There are, however, some demand headwinds. Consumer momentum in China has softened, and there have been some pressures in the U.S. market. Even so, the broader fundamental picture remains stable. For me, this is more of a defensive or downturn-resilience play. There is significant resistance overhead, but structurally the global demand for premium spirits remains intact over the long term. Bottom line. This is a quality compounder at a reasonable valuation, currently moving through a softer demand phase. It is not a deep value situation, and it is not clearly overvalued either. It leans more defensive than high growth. The stock looks more attractive on pullbacks rather than on strength. Chasing momentum here does not offer the best risk profile. Technically the structure is acceptable. Fundamentally the business remains sound. What is missing right now is a clear catalyst. This is likely a longer-term setup, in the two to three year horizon, rather than a fast momentum trade. Disclaimer: This content reflects personal market opinions and is shared for educational and informational purposes only. It does not constitute financial, investment, or trading advice. Always conduct your own research and assess your risk before making any investment decisions. Past performance is not indicative of future results.
XETR:PER
by Risk_Adj_Return
Wave 5 startupSynbiotic completed a symmetriec ABCDE triangle formation as a wave 4. This could result in a wave 5 forming up to a goal of 3,65 € ( 100% fiblvl)
TRADEGATE:SBXLong
by robschulz
BMW Example 2Business Summary Bayerische Motoren Werke AG (BMW) is a German-based company. The Company is engaged in the development and manufacturing of automobiles and motorcycles. Its business is divided into three segments: Automotive segment, Motorcycles segment, and Financial Services segment. The Automotive segment has three brands BMW, MINI and Rolls-Royce. The product range includes automobiles ranging from the compact class to the luxury class. The Motorcycles segment develops manufactures and sells motorcycles and scooters in the Sport, Tour, Roadster, Heritage, Adventure and Urban Mobility categories, as well as motorcycles for private use and special-purpose vehicles for operational use. The Financial Services segment offers credit financing and the leasing of BMW Group brand automobiles and motorcycles to retail customers. It also handles financing for dealerships and customer deposits.
XETR:BMW
by SilverArm
BMW-exampleBusiness Summary Bayerische Motoren Werke AG (BMW) is a German-based company. The Company is engaged in the development and manufacturing of automobiles and motorcycles. Its business is divided into three segments: Automotive segment, Motorcycles segment, and Financial Services segment. The Automotive segment has three brands BMW, MINI and Rolls-Royce. The product range includes automobiles ranging from the compact class to the luxury class. The Motorcycles segment develops manufactures and sells motorcycles and scooters in the Sport, Tour, Roadster, Heritage, Adventure and Urban Mobility categories, as well as motorcycles for private use and special-purpose vehicles for operational use. The Financial Services segment offers credit financing and the leasing of BMW Group brand automobiles and motorcycles to retail customers. It also handles financing for dealerships and customer deposits.
XETR:BMW
by SilverArm
VNA - Potential breakoutXETR:VNA potential breakout, looking for confirmation Disclaimer: This post is for educational purposes only and does not constitute financial, investment, or trading advice. Investing involves risk, and you may lose your capital. Past performance is not an indicator of future results. Please perform your own due diligence or consult a professional before making any investment decisions.
XETR:VNALong
by Paci
11
Bayer AG Seeks to Close the Roundup Legal FrontIon Jauregui – Analyst at ActivTrades German pharmaceutical and agrochemical giant Bayer is back in the spotlight after announcing a new effort to resolve the long-running litigation in the United States over the herbicide Roundup. The company has proposed a settlement of up to $7.25 billion to resolve approximately 65,000 claims related to alleged cancer cases, a direct legacy of its 2018 acquisition of Monsanto for $63 billion. The Monsanto deal, conceived as a strategic move to consolidate global leadership in crop science, became one of the most controversial corporate episodes of the past decade. Since then, Bayer has paid nearly $10 billion in settlements and faced multimillion-dollar verdicts, including a $2.1 billion judgment. The new plan involves structured payments over 21 years and does not constitute an admission of guilt, though it explicitly recognizes the financial cost associated with the litigation. Record Provisions and Cash Flow Pressure From an accounting perspective, Bayer expects to raise its legal provisions to €11.8 billion. The company also anticipates negative free cash flow in 2026 due to the payment schedule. This is particularly relevant for the market, which closely monitors debt levels, dividend policy, and the company’s capacity to sustain investment in research and development. Bayer’s strategy is to convert an uncertain and potentially unlimited legal risk into a quantified, time-distributed financial obligation. However, the settlement’s effectiveness will depend on judicial approval and the level of participation by plaintiffs. If acceptance falls short of the required threshold, legal exposure could remain. Market Reaction and Fundamental Reading The stock initially reacted positively, reflecting relief at the prospect of reducing the structural uncertainty that has weighed on the value since 2018. However, the initial enthusiasm gave way to caution as investors assessed the real impact on cash flow and the balance sheet. Fundamentally, the Roundup case has acted as a persistent discount on Bayer’s valuation multiples. While its pharmaceutical and agricultural businesses remain solidly positioned globally, the legal risk has influenced perceptions of the company’s financial profile. The key question is whether this extraordinary provision marks a turning point or simply redistributes the problem over time. Technical Analysis – Bayer AG (Ticker AT: BAYN): Structural Volatility Technically, the stock has continued an upward trend, expanding the distance between its 50-, 100-, and 200-day moving averages. The value remains highly sensitive to any judicial developments. Yesterday’s session lows, following the news, rested near the 50-day moving average, acting as a critical short- and medium-term support around €45.10. A breakdown could reignite selling pressure toward the 200-day moving average near €41.30. On the upside, the last highs of €49.78 on Tuesday acted as resistance; this price level has not been seen since September 2023. RSI has corrected strongly toward the mid-zone at 56.28%, while MACD shows a negative histogram but its signal line remains above, suggesting consolidation rather than a trend reversal. These resistance levels coincide with previous legal news announcements, where initial rebounds triggered selling. If the market responds positively to this management of an adverse ruling after upcoming earnings, prices could move above €50. Otherwise, the technical bias may remain constrained by the legal front, generating corrections to support zones at €41.47 and €32.78, respectively. An Attempt to Turn the Page Bayer is seeking to close one of the most burdensome chapters in its recent corporate history. The proposed settlement aims to transform an open legal risk into a structured, time-bound financial obligation, providing greater market visibility. However, this certainty comes at a cost: higher provisions and short- to medium-term cash flow pressure. For now, investors remain cautious. The final judicial outcome and the company’s ability to stabilize its balance sheet will be key to redefining its stock narrative in the coming years. Nonetheless, the stock’s performance in recent years suggests that, despite adverse rulings and the high legal cost, the market has gradually internalized much of this risk. The share price has repeatedly shown resilience after periods of high volatility, indicating that much of the impact may already be priced in. From this perspective, unless new disruptive factors arise, the legal front is unlikely to threaten the company’s long-term potential. ******************************************************************************************* The information provided does not constitute investment research. The material has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and such should be considered a marketing communication. All information has been prepared by ActivTrades ("AT"). The information does not contain a record of AT's prices, or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance and forecasting are not a synonym of a reliable indicator of future performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk. Political risk is unpredictable. Central bank actions can vary. Platform tools do not guarantee success.
XETR:BAYN
by ActivTrades
Infineon breakoutINF broke out! We are expecting continuation of this bullish price action, but a retest of the previous resistance is also expected. Always trade with risk management in place.
XETR:IFXLong
by ChartCombat
After the drop, is SAP stock an opportunity again?Like the major players in the software sector, SAP shares have corrected sharply on the stock market since spring 2025. The major stocks in this sector are facing unfavorable capital arbitrage as flows are shifting toward the AI sector. Historically pure and already very mature software companies have therefore seen capital outflows as investors reposition into stocks fully exposed to AI growth. However, software companies such as Adobe or SAP remain highly profitable and are starting to implement solid strategies to monetize AI. Last week, I reviewed the case of Adobe stock. Today, I am asking the same question for SAP shares: after a 45% drop in a few months, should one consider repositioning on the buy side for SAP stock? Financial market technical analysis and fundamental valuation analysis suggest that caution and patience are still warranted: • The real tangible support zone is rather located between €130 and €150 per share • From a valuation standpoint, SAP’s drop is not yet a fundamental opportunity in the same way as Adobe From a technical perspective, SAP’s monthly chart shows that the €170 area has now become an intermediate resistance, corresponding to a former support that has turned into a distribution zone. The stock experienced a very rapid bullish acceleration before correcting sharply, which often leaves room for prolonged consolidation phases. In this type of setup, it is common for the market to test deeper retracement areas before considering a sustainable recovery. The technical levels between €130 and €150 correspond to previous congestion zones and more credible Fibonacci retracement levels to build a medium-term entry point with a better risk/reward ratio. From a fundamental standpoint, valuation remains demanding despite the correction. By comparison, Adobe is trading at significantly lower earnings multiples, while its growth momentum remains solid and its cash generation capacity is comparable. For its part, SAP retains a strong strategic positioning in enterprise software, with a captive customer base and recurring revenues, but the market is already pricing in a good portion of the future benefits linked to the integration of AI into its solutions. In other words, SAP’s valuation premium remains partly justified by its quality, but it mechanically limits short-term re-rating potential. Finally, in a context of sector rotation that remains favorable to stocks directly exposed to AI, large “historical” software names continue to suffer from a relative attractiveness deficit compared with tech giants such as Microsoft. For a long-term investor, SAP remains a high-quality name to watch closely, but entry discipline is essential. A gradual, step-by-step approach on lower technical zones would allow repositioning with a greater margin of safety, rather than trying to catch an uncertain bottom. DISCLAIMER: This content is intended for individuals who are familiar with financial markets and instruments and is for information purposes only. The presented idea (including market commentary, market data and observations) is not a work product of any research department of Swissquote or its affiliates. This material is intended to highlight market action and does not constitute investment, legal or tax advice. If you are a retail investor or lack experience in trading complex financial products, it is advisable to seek professional advice from licensed advisor before making any financial decisions. This content is not intended to manipulate the market or encourage any specific financial behavior. Swissquote makes no representation or warranty as to the quality, completeness, accuracy, comprehensiveness or non-infringement of such content. The views expressed are those of the consultant and are provided for educational purposes only. Any information provided relating to a product or market should not be construed as recommending an investment strategy or transaction. Past performance is not a guarantee of future results. Swissquote and its employees and representatives shall in no event be held liable for any damages or losses arising directly or indirectly from decisions made on the basis of this content. The use of any third-party brands or trademarks is for information only and does not imply endorsement by Swissquote, or that the trademark owner has authorised Swissquote to promote its products or services. Swissquote is the marketing brand for the activities of Swissquote Bank Ltd (Switzerland) regulated by FINMA, Swissquote Capital Markets Limited regulated by CySEC (Cyprus), Swissquote Bank Europe SA (Luxembourg) regulated by the CSSF, Swissquote Ltd (UK) regulated by the FCA, Swissquote Financial Services (Malta) Ltd regulated by the Malta Financial Services Authority, Swissquote MEA Ltd. (UAE) regulated by the Dubai Financial Services Authority, Swissquote Pte Ltd (Singapore) regulated by the Monetary Authority of Singapore, Swissquote Asia Limited (Hong Kong) licensed by the Hong Kong Securities and Futures Commission (SFC) and Swissquote South Africa (Pty) Ltd supervised by the FSCA. Products and services of Swissquote are only intended for those permitted to receive them under local law. All investments carry a degree of risk. The risk of loss in trading or holding financial instruments can be substantial. The value of financial instruments, including but not limited to stocks, bonds, cryptocurrencies, and other assets, can fluctuate both upwards and downwards. There is a significant risk of financial loss when buying, selling, holding, staking, or investing in these instruments. SQBE makes no recommendations regarding any specific investment, transaction, or the use of any particular investment strategy. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The vast majority of retail client accounts suffer capital losses when trading in CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Digital Assets are unregulated in most countries and consumer protection rules may not apply. As highly volatile speculative investments, Digital Assets are not suitable for investors without a high-risk tolerance. Make sure you understand each Digital Asset before you trade. Cryptocurrencies are not considered legal tender in some jurisdictions and are subject to regulatory uncertainties. The use of Internet-based systems can involve high risks, including, but not limited to, fraud, cyber-attacks, network and communication failures, as well as identity theft and phishing attacks related to crypto-assets.
XETR:SAP
by Swissquote
Symmetrical triangleSymmetrical triangle on major support. Possible reversal here. Insiders buying.
XETR:RHMLong
by tisfluppe
BMW - +13% upside potential with 1:4 RRLooking good for a continuations play for the upper part of the ascending channel. Good R multiple of +4 Rotational play in EU and motors.
XETR:BMWLong
by subtlepapi
Siemens EnergyThis was my highest from last year. 600%. I believe it will go up to 200EUR. Right now I don't see clear indication, but this is my felling.
XETR:ENRLong
by serzz
Updated
Consolidation.Rheinmetal has been consolidating for 7 months now. Trading in a range between €1500 and €2000. We recently seen a drop back to the 1500s. Now we managed to test the €1650 resistance zone and we seem to be holding above €1600 support zone now. Earnings are getting closer and we could see new highs then.
XETR:RHMLong
by tisfluppe
One more high?Resistance at the moment There is also support levels in this graph
GETTEX:NVD
by RevoxVortex
IT'S JUST THE BEGINNING By leveraging the NVIDIA PhysicsNeMo framework, SK hynix engineers have fast-tracked the development of proprietary AI models that can unlock tools for significant innovation in device design and manufacturing. IT'S JUST THE BEGINNING (AND YOU KNOW IT) SK HYNIXXX
GETTEX:HY9HLong
by LX_fi
33
BMW is in a clear weekly uptrend, with price stair‑stepping highBMW is in a clear weekly uptrend, with price stair‑stepping higher as investors lean into its improving earnings profile, EV rollout, and capital returns. Management expects strong demand into 2026 and is backing that view with a sizeable 2025–2027 share buyback programme, which supports EPS growth and underpins the trend while Neue Klasse EV models ramp. This idea treats BMW as a trend‑following long!
XETR:BMWLong
by ConnectmyCurrency
Bayer-4h timeframe-bullish continuation Looks like Bayer is moving higher with wave 5 green, target 53. Bayer has been my favourite stock to analyze and trade. Recently I feel like assigning the personality traits of the asset I analyse. And this is Bayer personality. ✅ Interestingly, Bayer is a big German pharma corporation. And its personality based on my Elliot Wave analysis is also very German-like 😄 ✅ It is predictable and reliable. The wave counts are very clear and the stock has been behaving predictably as per my analysis. ✅ In Elliott Wave analysis, when you have a very clear wave count, it is an A setup. ✅ Post Elliott Wave analysis (incorporating into trading): Its reliability to perform and behave as like the count suggests is heaven for a trader. You don't want to trade a PERFECT wave count which turns out to be unreliable. So yeah, I like Bayer stock as an Elliott Wave analyst and trader. 😃
XETR:BAYNLong
by Sophia-ElliottWave
112233445566778899101011111212131314141515161617171818191920202121222223232424252526262727282829293030313132323333343435353636373738383939404041414242
…999999

Made by humans

Select market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.Copyright © 2026, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC filings and other documents provided by Quartr.© 2026 TradingView, Inc.

More than a product
  • Supercharts
Screeners
  • Stocks
  • ETFs
  • Bonds
  • Crypto coins
  • CEX pairs
  • DEX pairs
  • Pine
Heatmaps
  • Stocks
  • ETFs
  • Crypto coins
Calendars
  • Economic
  • Earnings
  • Dividends
  • IPOs
More products
  • News Flow
  • Portfolios
  • Fundamental Graphs
  • Yield Curves
  • Options
  • Macro Maps
  • Pine Script®
Apps
  • Mobile
  • Desktop
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
  • Paid Spaces
Tools & subscriptions
  • Features
  • Pricing
  • Market data
  • Gift plans
Trading
  • Overview
  • Brokers
  • Brokers comparison
  • The Leap
Special offers
  • CME Group futures
  • Eurex futures
  • US stocks bundle
About company
  • Who we are
  • Space mission
  • Blog
  • Help Center
  • Careers
  • Media kit
Merch
  • TradingView store
  • Tarot cards for traders
  • The C63 TradeTime
Policies & security
  • Terms of Use
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Accessibility Statement
  • Security tips
  • Bug Bounty program
  • Status page
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
  • Paid Spaces
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Look FirstLook First